STAT3 Signalling Drives LDH Up-Regulation and Adiponectin Down-Regulation in Cachectic Adipocytes

Area of Science:

• Oncology
• Molecular Biology
• Metabolism

Background:

• Cachexia significantly impairs cancer patient quality of life and treatment efficacy.
• Understanding the molecular mechanisms of cachexia in adipocytes is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the impact of colon carcinoma secretome on adipocyte metabolism.
• To identify key signaling pathways involved in cancer-induced cachexia in fat cells.

Main Methods:

• Treatment of murine and human adipocytes with secretome from CT26 colon carcinoma cells.
• Assessment of metabolic alterations, including lactate production and oxygen consumption.
• Inhibition of lactate dehydrogenase with oxamate and STAT3 signaling with WP1066.

Main Results:

• CT26 secretome induced cachectic features in adipocytes, characterized by increased lactate production and reduced oxygen consumption.
• Oxamate treatment partially reversed the metabolic effects of the CT26 secretome.
• CT26 secretome increased lactate dehydrogenase and decreased adiponectin expression, mediated by the STAT3 signaling pathway.

Conclusions:

• The STAT3 signaling cascade is a key driver of metabolic alterations in adipocytes during cancer-associated cachexia.
• Targeting STAT3 signaling may offer a therapeutic approach to mitigate cachexia-related metabolic dysfunction.
• These findings advance the understanding of cachexia pathogenesis at the cellular and molecular level.